SavedAdd your journal

Journals / Anadolu Kardiyoloji Dergisi / 2008 / Cilt: 8 - Sayı: 1

Effect of intravenous positive inotropic therapy on myocardial damage in patients with dilated cardiomyopathy

Dilate kardiyomiyopatili hastalarda intravenöz pozitif inotropik tedavinin miyokard hasarı üzerine etkisi

Fulya ALBAYRAK
Muharrem ARSLANDAĞ
Mustafa YAZICI
Sabri DEMİRCAN
Pages
0–0
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

ALBAYRAK, F., ARSLANDAĞ, M., YAZICI, M., DEMİRCAN, S. (2022). Effect of intravenous positive inotropic therapy on myocardial damage in patients with dilated cardiomyopathy. Anadolu Kardiyoloji Dergisi, Cilt: 8 - Sayı: 1, 0–0. https://ajindex.com/articles/436986

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA, et al. Apoptosis in the failing human heart. N Engl J Med 1997; 336: 1131-41
  2. O'Connor CM, Gattis WA, Uretsky BF, Adams KF, McNulty SE, Grossman SH, et al. Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: Insights from the Flolan International Randomized Survival Trial (FIRST). Am Heart J 1999; 138: 78-86
  3. Krell MJ, Kline EM, Bates ER, Hodgson JM, Dilworth LR, Laufer N, et al. Intermittent, ambulatory dobutamine infusions in patients with severe congestive heart failure. Am Heart J 1986; 112: 787-91
  4. Eryol NK, Guven M, Topsakal R, Sungur M, Ozdogru I, Inanc T, et al. Is intermittent dobutamine treatment beneficial in patients with dilated cardiomyopathy? Anadolu Kardiyol Derg 2002; 2: 220-3.